Search Results - "Kang, Sung‐Woon"
-
1
Comparison of secondary attack rate and viable virus shedding between patients with SARS‐CoV‐2 Delta and Omicron variants: A prospective cohort study
Published in Journal of medical virology (01-01-2023)“…There are limited data comparing the transmission rates and kinetics of viable virus shedding of the Omicron variant to those of the Delta variant. We compared…”
Get full text
Journal Article -
2
Virological characteristics and the rapid antigen test as deisolation criteria in immunocompromised patients with COVID‐19: A prospective cohort study
Published in Journal of medical virology (01-11-2023)“…There are limited data supporting current Centers for Disease Control and Prevention guidelines for the isolation period in moderate to severely…”
Get full text
Journal Article -
3
Comparison of culture-competent virus shedding duration of SARS-CoV-2 Omicron variant in regard to vaccination status: A prospective cohort study
Published in Vaccine (24-04-2023)“…Previous studies have shown that fully vaccinated patients with SARS-CoV-2 Delta variants has shorter viable viral shedding period compared to unvaccinated or…”
Get full text
Journal Article -
4
A Novel Predictive Multi-Marker Test for the Pre-Surgical Identification of Ovarian Cancer
Published in Cancers (01-11-2023)“…Ovarian cancer remains the most lethal of gynecological malignancies, with the 5-year survival below 50%. Currently there is no simple and effective…”
Get full text
Journal Article -
5
Antibody responses as correlates of protection against SARS‐CoV‐2 in the Omicron era: A 5‐month prospective cohort study in Korean healthcare workers
Published in Clinical and translational medicine (01-01-2024)“…With the optimal cutoff values determined from the receiver operating characteristic curves (Figure S4), multivariable Cox regression analysis showed that…”
Get full text
Journal Article -
6
-
7
Characteristics and risk factors of prolonged viable virus shedding in immunocompromised patients with COVID-19: a prospective cohort study
Published in The Journal of infection (01-04-2023)“…•Immunocompromised patients with COVID-19 shed viable virus for median 4 weeks.•B-cell depleting therapy increases the risk of prolonged viable viral…”
Get full text
Journal Article -
8
Comparison of the clinical and virological characteristics of SARS-CoV-2 Omicron BA.1/BA.2 and omicron BA.5 variants: A prospective cohort study
Published in The Journal of infection (01-05-2023)“…•Data about symptoms and viral kinetics of omicron BA.5 is lacking.•We thus compared the symptoms and viral kinetics between SARS-CoV-2 omicron BA.1/BA.2 and…”
Get full text
Journal Article -
9
Clinical Characteristics of and Risk Factors for Subsequent Carbapenemase-producing Enterobacterales (CPE) Bacteraemia in Rectal CPE Carriers
Published in International journal of antimicrobial agents (01-11-2023)“…•The rise of carbapenemase-producing Enterobacterales (CPE) is concerning due to high mortality and limited treatment options.•KPC producer (or CP-K…”
Get full text
Journal Article -
10
False positive Aspergillus galactomannan assay results caused by specific parenteral nutrition
Published in Medical mycology (Oxford) (04-09-2023)“…Abstract In September 2022, the proportion of clinically false positive results with high index values for the galactomannan (GM) assay increased dramatically…”
Get full text
Journal Article -
11
Clinical safety of remdesivir therapy in COVID-19 patients with renal insufficiency
Published in Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy (01-04-2024)“…Though remdesivir benefits COVID-19 patients, its use in those with renal dysfunction is currently limited due to concerns about possible toxic effects of…”
Get full text
Journal Article -
12
Comparison of the causes of death associated with delta and Omicron SARS-CoV-2 variants infection
Published in Journal of infection and public health (01-01-2023)Get full text
Journal Article -
13
-
14
The Association Between Antibody Responses and Prolonged Viable Severe Acute Respiratory Syndrome Coronavirus 2 Shedding in Immunocompromised Patients: A Prospective Cohort Study
Published in The Journal of infectious diseases (14-06-2024)“…Immunocompromised patients with coronavirus disease 2019 were prospectively enrolled from March to November 2022 to understand the association between antibody…”
Get full text
Journal Article -
15
Quantitative interferon-gamma releasing assay in predicting tuberculosis in South Korean military: a retrospective cohort study
Published in Clinical microbiology and infection (01-10-2024)“…The interferon-gamma releasing assay (IGRA) has been widely used to diagnose latent tuberculosis infection (TBI). However, there are limited data on the…”
Get more information
Journal Article -
16
Clinical scoring system to predict viable viral shedding in patients with COVID-19
Published in Journal of clinical virology (01-12-2022)“…•A clinical scoring system to predict viable SARS-CoV-2 viral shedding.•The 4-factor model including viral copy number, severity, organ transplant, and…”
Get full text
Journal Article -
17
-
18
-
19
464. Whole Genome Sequencing and Mutation Analysis of SARS-CoV-2 in the Immunocompromised Patients with Persistent SARS-CoV-2 Shedding
Published in Open forum infectious diseases (27-11-2023)“…Abstract Background Immunocompromised individuals could be sources of new SARS-CoV-2 variants as the virus can reside in them for extended periods, acquiring…”
Get full text
Journal Article -
20
Protracted course of SARS-CoV-2 pneumonia in moderately to severely immunocompromised patients
Published in Clinical and experimental medicine (01-10-2023)“…There have been few studies comparing the clinical characteristics and outcomes of SARS-CoV-2 pneumonia in individuals with and without moderately to severely…”
Get full text
Journal Article